# Allonnia

> Allonnia is a Boston-based environmental biotechnology company that uses biology and engineered systems to solve stubborn contamination and resource-recovery problems. Spun out of Ginkgo Bioworks' Ferment Consortium in 2020, it removes PFAS from water at scale using SAFF foam-fractionation technology and is commercializing biological methods to recover critical minerals and rare earth elements from ore. The company has raised more than $100 million to bring 'bio-ingenuity' to water treatment and mining.

- **Founded:** 2020
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Ginkgo Bioworks (Ferment Consortium) (Founding parent / incubator), Nicole Richards (CEO (appointed at launch))
- **Team size:** ~56 employees
- **Products:** SAFF (Surface Active Foam Fractionation), SAFF 10, D-Solve, RE-Cover, PFAS treatability studies
- **Notable:** First company to launch out of Ginkgo Bioworks' Ferment Consortium (2020), Raised more than $100 million in total funding, SAFF treated more than 160 million gallons of PFAS-contaminated water in its first two years in North America

## Products & services

- **SAFF (Surface Active Foam Fractionation)** — A PFAS water-treatment technology (created by EPOC Enviro, distributed by Allonnia in North America) that uses rising air bubbles to lift and concentrate PFAS out of contaminated water, removing up to 99.99% of regulated PFAS without chemicals or adsorption media and producing a low-volume concentrate for destruction.
- **SAFF 10** — A compact, mobile PFAS treatment system designed for small-scale sites, bringing sustainable remediation to locations that don't need large fixed installations.
- **D-Solve** — A biological mineral-upgrading process that uses a selective, recyclable Allonnia Biosolution to dissolve problematic gangue minerals from ore concentrates, delivering cleaner, higher-value concentrates as a bolt-on step in existing mining flowsheets.
- **RE-Cover** — Technology aimed at capturing and recovering rare earth elements.
- **PFAS treatability studies** — Bench-scale treatability studies for PFAS-contaminated sites to validate SAFF performance before deployment.

## Achievements

- First company to launch out of Ginkgo Bioworks' Ferment Consortium (2020)
- Raised more than $100 million in total funding
- SAFF treated more than 160 million gallons of PFAS-contaminated water in its first two years in North America
- Demonstrated D-Solve biological mineral dissolution at industrial timescales inside a working North American nickel mine
- Launched SAFF 10 compact mobile PFAS unit for small-scale sites
- Extended SAFF to remove short-chain PFAS compounds

## Latest updates

- **2025-12** — Raised more than $20 million in a Series A extension led by Viking Global Investors, pushing total funding past $100 million to accelerate critical-materials biotechnology.
- **2025** — Launched SAFF 10, a compact mobile PFAS treatment system for small-scale sites in North America.
- **2025** — Announced first successful demonstration of its D-Solve mining biosolubilization solution.
- **2024** — Partnered with Battelle to co-host the 2025 Bioremediation and Environmental Biotechnology Conference and began offering bench-scale PFAS treatability studies.

## Links

- Website: https://allonnia.com
- LinkedIn: https://www.linkedin.com/company/allonnia
- Twitter/X: https://twitter.com/allonniabio
- YouTube: https://www.youtube.com/channel/UCeA9_lnE4CLV3vrv9Nlq3sQ

---

Profile page: https://yespress.io/allonnia
Published by YesPress — https://yespress.io
Last updated: 2026-07-22